Gallagher Fiduciary Buys Million in Vanguard VCLT Move
A major fiduciary manager disclosed a sizable purchase in the Vanguard Long-Term Corporate Bond ETF, signaling a stra...
What Are The Dangers Of Holding Cash
Learn about the dangers of holding cash. This guide will help you understand the potential risks involved with cash savings.
18,190 articles
Are There Bitcoin Mining Stocks Worth Buying Right Now?
As miners shift capital from BTC holdings to AI compute, the landscape for there bitcoin mining stocks changes. This ...
Four ETFs Deliver $500+ Monthly Income on $100,000
A new income-focused ETF blend aims to provide steady monthly cash flow even as markets swing. By splitting $100,000 ...
Palantir $11.2 Billion Revenue Backlog: Buy for 2026?
Palantir has a large revenue backlog, a major Army contract on the books, and ambitious growth guidance. This analysi...
Inside the Billionaire Bill Ackman Hedge: AI Bets That Win
A billionaire hedge fund manager shows the power of high-conviction bets in AI. This article breaks down Ackman'...
Peabody Energy Other Coal Rally Today: What’s Driving It
Coal stocks moved higher as energy markets tensed. This piece breaks down why peabody energy other coal names jumped,...
Thursday Reads: 10 Morning Investing Briefs for Thursday
Kick off your day with ten concise investing reads tailored for Thursday mornings. From market trends to AI disruptio...
Super Micro Doubled Revenue, Yet Stock Remains Flat
Super Micro Computer reports revenue that more than doubles year over year, yet the shares sit flat as questions abou...
BuzzFeed Blows Past Debt Deadline, Raising Bankruptcy Fears
BuzzFeed wins a brief reprieve on a $5 million debt due May 18, after a prior going-concern warning. The move spooks ...
Half Million Dollars From Three Tickers: $3,100/Month Income
Three ETFs can deliver roughly $37,000 a year on a $500,000 portfolio, providing about $3,100 a month without selling...
Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status